Department of Cardiovascular Surgery, Instituto do Coração, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Braz J Cardiovasc Surg. 2023 Apr 23;38(2):244-247. doi: 10.21470/1678-9741-2021-0074.
Left internal thoracic artery to left anterior descending artery (LITA-LADA) grafting has become a fundamental part of coronary artery bypass grafting (CABG). This grafting has led to an increased use of other arterial conduits, of which the radial artery (RA) is the most popular. Whether RA can have the same long-term patency as LITA is controversial. The objective of this study is to access the long-term clinical follow-up and, when available, the patency rate of RA grafts.
Twenty-six patients from a previous study with critical stenosis in all target vessels underwent complete arterial CABG with LITA and RA grafts from 1996 to 2003. They all underwent midterm multidetector computed tomography after surgery with the association of at least one patent LITA and one patent RA graft.
Twelve patients (46%) are alive with no angina symptoms. Six patients underwent a second image exam 12 to 16 years (average of 14 years) after surgery, with a total of six LITA-LADA and 14 RA grafts with 100% patency rate. Clinical follow-up five to 23 years after surgery (average of 14 years) showed only one death 12 years after surgery related to coronary artery disease (CAD) (3,8%). Another 12 patients died of non-CAD.
Patients with midterm associated LITA and RA patent grafts show similar optimal long-term patency rates of both types of grafts with excellent clinical outcome.
左内乳动脉至左前降支(LITA-LADA)搭桥术已成为冠状动脉旁路移植术(CABG)的基本组成部分。这种搭桥术导致其他动脉移植物的使用增加,其中桡动脉(RA)最为流行。RA 的长期通畅率是否与 LITA 相同存在争议。本研究旨在评估长期临床随访结果,以及 RA 移植物的通畅率(如果有的话)。
1996 年至 2003 年,26 例来自先前研究的患者存在所有靶血管的临界狭窄,接受了 LITA 和 RA 移植物的完全动脉 CABG。所有患者均在术后接受中期多排 CT 检查,至少有一条通畅的 LITA 和一条通畅的 RA 移植物。
12 名患者(46%)存活且无胸痛症状。6 名患者在术后 12 至 16 年(平均 14 年)接受了第二次图像检查,共有 6 条 LITA-LADA 和 14 条 RA 移植物,通畅率为 100%。术后 5 至 23 年(平均 14 年)的临床随访显示,仅 1 名患者在术后 12 年因冠状动脉疾病(CAD)死亡(3.8%)。另外 12 名患者死于非 CAD。
中期伴有 LITA 和 RA 移植物通畅的患者,两种类型移植物的长期通畅率均相似,且临床结果良好。